Effect of coadministration of corticosteroids on the development of contact sensitization

被引:15
作者
Amkraut, AA [1 ]
Jordan, WP [1 ]
Taskovich, L [1 ]
机构
[1] DERMATOL RES,RICHMOND,CA
关键词
D O I
10.1016/S0190-9622(96)90491-0
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Transdermal administration of drugs can increase patient compliance and reduce side effects, but it can also cause contact sensitization. Corticosteroids frequently are used to suppress the local immune response; however, their use as a pretreatment for transdermal system application sites is not practical. Objective: Our purpose was to determine the feasibility of suppressing contact sensitization by delivering a corticosteroid with the transdermal delivery systems. Methods: Materials were applied continuously for 3 weeks to the same (protocol SS) or different (protocol AS) skin sites. Skin flux and appearance of sensitization were determined. Results: Coadministration of hydrocortisone reduced the incidence of sensitization by d-chlorpheniramine and benzoyl peroxide from 45% to 7.5% and from 20% to 2.3%, respectively, under protocol SS. Under protocol AS, sensitization by d-chlorpheniramine was reduced from 15% to 1%. Frequent exposure to the sensitizer plus corticosteroid induced tolerance to the sensitizer. Conclusion: Sensitization by moderately immunogenic drugs after any length of exposure may be reduced to acceptable levels by the coadministration of hydrocortisone.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 27 条
[1]   FLOW CYTOMETRICALLY-SORTED RESIDUAL HLA-DR+T6+ LANGERHANS CELLS IN TOPICAL STEROID-TREATED HUMAN-SKIN EXPRESS NORMAL AMOUNTS OF HLA-DR AND CD1A T6 ANTIGENS AND EXHIBIT NORMAL ALLOANTIGEN-PRESENTING CAPACITY [J].
ASHWORTH, J ;
KAHAN, MC ;
BREATHNACH, SM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (02) :258-262
[2]  
Becker D, 1993, Exp Dermatol, V2, P63, DOI 10.1111/j.1600-0625.1993.tb00010.x
[3]   EFFECT OF GLUCOCORTICOSTEROIDS ON EPIDERMAL LANGERHANS CELLS [J].
BELSITO, DV ;
FLOTTE, TJ ;
LIM, HW ;
BAER, RL ;
THORBECKE, GJ ;
GIGLI, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (01) :291-302
[4]   MODULATION OF EXPRESSION OF EPIDERMAL LANGERHANS CELL PROPERTIES FOLLOWING INSITU EXPOSURE TO GLUCOCORTICOSTEROIDS [J].
BERMAN, B ;
FRANCE, DS ;
MARTINELLI, GP ;
HASS, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1983, 80 (03) :168-171
[5]   CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].
BEUTLER, B ;
KROCHIN, N ;
MILSARK, IW ;
LUEDKE, C ;
CERAMI, A .
SCIENCE, 1986, 232 (4753) :977-980
[6]   INHIBITION OF INDUCTION OF HUMAN CONTACT SENSITIZATION BY TOPICAL GLUCOCORTICOSTEROIDS [J].
BURROWS, WM ;
STOUGHTON, RB .
ARCHIVES OF DERMATOLOGY, 1976, 112 (02) :175-178
[7]  
CUMBERBATCH M, 1992, IMMUNOLOGY, V75, P257
[8]  
Fregert S., 1981, MANUAL CONTACT DERMA, P71
[9]   DIRECT EFFECTS OF GLUCOCORTICOSTEROIDS ON EPIDERMAL LANGERHANS CELLS [J].
FURUE, M ;
KATZ, SI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) :342-347
[10]   INHIBITION OF LANGERHANS CELL ATPASE AND CONTACT SENSITIZATION BY LANTHANIDES - ROLE OF T-SUPPRESSOR CELLS [J].
GRUNER, S ;
DIEZEL, W ;
STRUNK, D ;
ECKERT, R ;
SIEMS, W ;
ANHALT, GJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (03) :478-482